Synopsys, Inc. $SNPS Position Boosted by DAVENPORT & Co LLC

DAVENPORT & Co LLC grew its holdings in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 304.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,444 shares of the semiconductor company’s stock after purchasing an additional 9,370 shares during the period. DAVENPORT & Co LLC’s holdings in Synopsys were worth $5,845,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in SNPS. Barden Capital Management Inc. increased its stake in Synopsys by 1.2% in the 4th quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock valued at $877,000 after buying an additional 23 shares during the period. Mutual Advisors LLC lifted its position in Synopsys by 2.1% in the 3rd quarter. Mutual Advisors LLC now owns 1,157 shares of the semiconductor company’s stock worth $528,000 after buying an additional 24 shares in the last quarter. Alpine Bank Wealth Management boosted its stake in shares of Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after buying an additional 25 shares during the period. Valeo Financial Advisors LLC boosted its stake in shares of Synopsys by 3.9% during the 3rd quarter. Valeo Financial Advisors LLC now owns 666 shares of the semiconductor company’s stock valued at $329,000 after buying an additional 25 shares during the period. Finally, Blume Capital Management Inc. grew its holdings in shares of Synopsys by 8.9% during the 3rd quarter. Blume Capital Management Inc. now owns 305 shares of the semiconductor company’s stock valued at $150,000 after acquiring an additional 25 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Stock Down 2.0%

SNPS opened at $401.95 on Friday. The business has a 50 day moving average price of $445.36 and a 200 day moving average price of $453.39. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The firm has a market cap of $77.00 billion, a P/E ratio of 62.41, a price-to-earnings-growth ratio of 3.34 and a beta of 1.15.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating the consensus estimate of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The company had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. During the same quarter last year, the company posted $3.03 earnings per share. The company’s revenue for the quarter was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Activity

In related news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.56% of the company’s stock.

Analyst Upgrades and Downgrades

SNPS has been the topic of a number of research reports. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their price target for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Rosenblatt Securities reduced their price objective on Synopsys from $560.00 to $530.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Morgan Stanley restated an “equal weight” rating and issued a $480.00 target price (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the stock a “buy” rating in a research report on Wednesday, February 25th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research note on Thursday, January 22nd. Eight investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $531.00.

View Our Latest Report on Synopsys

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Further Reading

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.